ATE401904T1 - Zusammensetzung mit radix codonopsis pilosulae und radix astragali zur behandlung von akuten lungenverletzungen - Google Patents

Zusammensetzung mit radix codonopsis pilosulae und radix astragali zur behandlung von akuten lungenverletzungen

Info

Publication number
ATE401904T1
ATE401904T1 AT04702624T AT04702624T ATE401904T1 AT E401904 T1 ATE401904 T1 AT E401904T1 AT 04702624 T AT04702624 T AT 04702624T AT 04702624 T AT04702624 T AT 04702624T AT E401904 T1 ATE401904 T1 AT E401904T1
Authority
AT
Austria
Prior art keywords
radix
composition
treatment
lung injury
acute lung
Prior art date
Application number
AT04702624T
Other languages
English (en)
Inventor
Weihong Xie
Chunhan Zhi
Desheng Tao
Original Assignee
Li Min Pharmaceutical Factory
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CNA031230458A external-priority patent/CN1513497A/zh
Priority claimed from CN 03137351 external-priority patent/CN1245172C/zh
Priority claimed from CN 03156284 external-priority patent/CN1284547C/zh
Application filed by Li Min Pharmaceutical Factory filed Critical Li Min Pharmaceutical Factory
Application granted granted Critical
Publication of ATE401904T1 publication Critical patent/ATE401904T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/34Campanulaceae (Bellflower family)
    • A61K36/344Codonopsis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/481Astragalus (milkvetch)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/16Emollients or protectives, e.g. against radiation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Vascular Medicine (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Toxicology (AREA)
  • Dermatology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT04702624T 2003-04-29 2004-01-16 Zusammensetzung mit radix codonopsis pilosulae und radix astragali zur behandlung von akuten lungenverletzungen ATE401904T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CNA031230458A CN1513497A (zh) 2003-04-29 2003-04-29 一种调节免疫的组合物药物及其制备方法
CN 03137351 CN1245172C (zh) 2003-06-18 2003-06-18 党参黄芪组合物在制备治疗缺血性心脏病的药物中的用途
CN 03156284 CN1284547C (zh) 2003-09-02 2003-09-02 党参黄芪组合物在预防与治疗急性肺损伤中的用途

Publications (1)

Publication Number Publication Date
ATE401904T1 true ATE401904T1 (de) 2008-08-15

Family

ID=33424254

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04702624T ATE401904T1 (de) 2003-04-29 2004-01-16 Zusammensetzung mit radix codonopsis pilosulae und radix astragali zur behandlung von akuten lungenverletzungen

Country Status (7)

Country Link
US (4) US20060110473A1 (de)
EP (1) EP1523988B1 (de)
JP (2) JP2006524639A (de)
AT (1) ATE401904T1 (de)
DE (1) DE602004015219D1 (de)
HK (1) HK1072374A1 (de)
WO (1) WO2004096249A1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY147497A (en) * 2005-10-12 2012-12-14 Government Of Malaysia As Represented By The Ministry Of Science Technology And Innovation Malaysia Process for preparation of labisia pumila extract
CN101912469A (zh) * 2010-05-25 2010-12-15 中国人民解放军军事医学科学院放射与辐射医学研究所 一种补中益气丸提取物的辐射防护用途
US8858953B2 (en) * 2011-05-09 2014-10-14 Yu-Hwa Peter Sheng Herbal composition for treating cancer
CN102614471B (zh) * 2012-04-24 2013-12-04 山东大学齐鲁医院 一种治疗乳腺癌的中药
CN102697891A (zh) * 2012-06-15 2012-10-03 李良 治疗心悸的黄芪中药汤剂及制备方法
US9005676B2 (en) 2012-09-21 2015-04-14 Hong Kong Baptist University Pharmaceutical composition and methods for modulating immune system, preventing, pretreating and/or treating cancers
US9265810B2 (en) * 2012-09-21 2016-02-23 Hong Kong Baptist University Pharmaceutical composition and methods for modulating immune system, preventing, pretreating and/or treating cancers
CN102935130B (zh) * 2012-12-08 2014-03-19 新乡医学院 一种提高缺氧耐受力的中药组合物及其制备方法和应用
JPWO2014104162A1 (ja) * 2012-12-26 2017-01-12 興和株式会社 医薬
TWI590830B (zh) * 2014-04-15 2017-07-11 財團法人工業技術研究院 促進幹細胞分化及作爲心肌梗塞癒後保養的活性成分
CN104273526B (zh) * 2014-06-13 2016-08-24 无限极(中国)有限公司 一种具有缓解肺气虚、清肺毒、增强肺部免疫力功效的功能食品
JP2018507907A (ja) * 2014-12-09 2018-03-22 上海交通大学医学院附属第九人民医院No.9 People Hospital Affiliated To Shanghai Jiaotong University School Of Medicine アトラクチレノリド(atractylenolide)系化合物またはその誘導体の応用及び血小板凝集抑制薬
CN104706708B (zh) * 2015-02-13 2018-11-20 兰州大学 红芪乙醇提取物在制备预防和治疗肝纤维化药物中的应用及其中有效成分鉴定方法
CN108066668A (zh) * 2017-12-29 2018-05-25 山东东阿东方阿胶股份有限公司 一种健脾补气八珍膏的制备方法
CN109394826B (zh) * 2018-09-29 2021-07-13 兰州大学 一种蜜炙红芪饮片的制备方法
KR102159976B1 (ko) * 2019-01-10 2020-09-25 주식회사농심 면역 증진용 조성물, 이를 포함하는 의약 및 기능성 식품
CN113577224A (zh) * 2021-08-25 2021-11-02 徐州康正中医药科技有限公司 一种专用于产褥期妇女服用的药食同源的补气,补血,补虚的中药方
CN114831932B (zh) * 2022-04-11 2023-08-08 中山市恒生药业有限公司 一种参芪提取浓缩液、参芪口服液及其制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1089146A (zh) * 1993-01-01 1994-07-13 广州华乐制药厂 一种补中益气药及其制备方法
CN1084762A (zh) * 1993-08-01 1994-04-06 黄勇 八宝寿世保健酒的制备方法
CN1097330A (zh) * 1994-04-11 1995-01-18 张平 血力口服液及其制取方法
CN1217204A (zh) * 1997-11-19 1999-05-26 黄国泉 一种养肌复力药物及其制备方法
CN1266707A (zh) * 1999-03-15 2000-09-20 向加凌 抗衰老保健茶及工艺
CN1362102A (zh) * 2001-01-04 2002-08-07 杨孟君 纳米参芪制剂药物及其制备方法
JP2002356433A (ja) * 2001-05-30 2002-12-13 Tendou Seiyaku Kk 免疫賦活剤
CN1222298C (zh) * 2001-06-26 2005-10-12 邓大勇 一种治疗心血管病的药物
TWI275396B (en) * 2001-10-17 2007-03-11 Braingenesis Biotechnology Co Composition of traditional Chinese medicines for preventing and treating cerebrovascular disease
CN1415341A (zh) * 2002-08-16 2003-05-07 夏义深 参芪抗病颗粒
CN1456242A (zh) * 2003-02-18 2003-11-19 毛友昌 加味归芪胶囊的制备方法
CN1456262A (zh) * 2003-02-20 2003-11-19 毛友昌 参芪胶囊的制备方法

Also Published As

Publication number Publication date
JP2011052005A (ja) 2011-03-17
HK1072374A1 (en) 2005-08-26
JP2006524639A (ja) 2006-11-02
US20080206375A1 (en) 2008-08-28
US20090169660A1 (en) 2009-07-02
US20060110473A1 (en) 2006-05-25
US20080206374A1 (en) 2008-08-28
EP1523988A1 (de) 2005-04-20
EP1523988B1 (de) 2008-07-23
WO2004096249A1 (fr) 2004-11-11
EP1523988A4 (de) 2006-09-13
DE602004015219D1 (de) 2008-09-04

Similar Documents

Publication Publication Date Title
HK1072374A1 (en) Composition comprising radix codonopsis pilosulae and radix astragali for the treatment of acute lung injury
ATE399553T1 (de) Pharmazeutische zusammensetzungen mit dextromethorphan und chinidin zur behandlung von neurologischen erkrankungen
DE602004029580D1 (de) Substituierte indolderivate für eine pharmazeutische zusammensetzung zur behandlung von atemwegserkrankungen
DE50213966D1 (de) pium, Ciclesonide UND einem BETAMIMETIKum ZUR BEHAMWEGSERKRANKUNGEN
WO2005065242A3 (en) Method of treating cancer using platelet releasate
BRPI0415373A (pt) ácidos carboxìlicos macrocìclicos e acilsulfonamidas como inibidores de replicação de hcv
BRPI0412273A (pt) material de zeólito, método de preparação do mesmo, preparação farmacêutica, uso de um material de zeólito, artigo médico, produto cosmético e/ou de higiene pessoal, e, métodos de liberação de óxido nìtrico, e de tratamento ou profilaxia de um indivìduo em necessidade do mesmo
DE60239648D1 (de) Pharmazeutische Zusammensetzungen zur Behandlung von Asthma
DE60021547D1 (de) Verfahren und vorrichtung zur herstellung und behandlung von elastomeren verbundwerkstoffen, und durch das verfahren herstellbarer elastomerer verbundwerkstoff
CY2007033I2 (el) Μεθοδος και φαρμακευτικο σκευασμα για την αντιμετωπιση της αντιστασης στα αντιυπερτασικα φαρμακα και για σχετικες παθησεις
IL226313A0 (en) A method for producing gamma-carboxylated human prothrombin, isolated prothrombin produced by such a method, a pharmaceutical preparation including it and its use as drugs and for the production of drugs for the treatment of blood coagulation
CY1108401T1 (el) Παραγωγα πυρρολοϊμιδαζολης, η παρασκευη τους, φαρμακευτικες συνθεσεις που τα περιεχουν και η χρηση τους ως νοοτροπικων παραγοντων
DE60233433D1 (de) PHARMAZEUTISCHE ZUBEREITUNG enthaltend ein Catechin, Ascorbinsäure, Prolin und Lysin ZUR BEHANDLUNG VON NEOPLASTISCHEN KRANKHEITEN
AU2003271021A8 (en) Immunogen for preparation of therapeutic vaccines or drugs for treatment of hepatitis b and the producing method and use thereof
DE60312505D1 (de) Injektion aus ixeris sonchifolia zur behandlung von kardiozerebralen gefässerkrankungen und funduserkrankungen sowie herstellungsverfahren dafür
ATE250437T1 (de) Hämokompatible oberflächen und verfahren zu deren herstellung
DE60111574D1 (de) Bisphosphonate-enthaltenden zusammensetzungen zur vorbeugung und/oder heilung von metabolischen knochenkrankheiten, verfahren zu ihren herstellung und benutzung dieser zusammensetzungen
ATE277625T1 (de) Pharmazeutische zusammensetzung aus spinnengiften sowie deren herstellung und verwendung zur behandlung von tumorerkrankungen
DE69809284D1 (de) Immunomodulator mit anti-mikrobakteriellen und anti-mykobakteriellen eigenschaften, verfahren zu seiner herstellung und pharmazeutische zusammensetzungen zur behandlung von mykobakteriosen sowie von chronischen und nicht-spezifischen lungenzuständen, sexuell übertragbaren krankheiten und den daraus resultierenden immunschwächen
ATE110269T1 (de) Ipriflavone enthaltende pharmazeutische zubereitungen, verfahren zur herstellung und therapeutische verwendung.
ATE426410T1 (de) Behandlung der oralen und darm mukositis durch verabreichung von menschlichem il-18
DE602004025103D1 (de) Heilkräuterzusammensetzung zur Behandlung von AIDS
DE60202684D1 (de) Pflanzenpräparat zur behandlung und heilung von bronchialen respiratorischen schwierigkeiten
DE602004029993D1 (de) Pharmazeutische zusammensetzung zur behandlung von drogenabhängigkeit
ATE301452T1 (de) Verfahren zur herstellung einer flüssigen dosierungseinheit und kit

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties